Search Within

David Hyman

  1. "Center for Pancreatic Cancer Research"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (30)
  3. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (66)
  2. Department of Medicine (66)
  3. Early Drug Development Service (66)
  4. Solid Tumor Oncology Division (66)
  5. GSK Faculty (54)
  6. Department of Pathology and Laboratory Medicine (51)

More Groups

People
  1. Michael Berger (44)
  2. David Solit (37)
  3. Ahmet Zehir (35)
  4. Marc Ladanyi (29)
  5. Zsofia Stadler (25)
  6. Mark Robson (23)

More People

Years
  1. 2021 (1)
  2. 2020 (8)
  3. 2019 (20)
  4. 2018 (15)
  5. 2017 (10)
  6. 2016 (7)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Cancer Research (9)
  3. Clinical Cancer Research (5)
  4. Annals of Oncology (4)
  5. Cancer Discovery (4)
  6. JAMA Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (19)
  2. American Society of Clinical Oncology (19)
  3. Nature Publishing Group (6)
  4. American Medical Association (5)
  5. Oxford University Press (4)
  6. American Society of Hematology (2)

More Publishers

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline variants in targeted tumor sequencing using matched normal DNA
    Journal Article

    Schrader, K. A.; Cheng, D. T.; Joseph, V.; Prasad, M.; Walsh, M.; Zehir, A.; Ni, A.; Thomas, T.; Benayed, R.; Ashraf, A.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Lurbinectedin (PM01183) in combination with paclitaxel (P) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Garralda, E.; Stathis, A.; Drilon, A.; Boni, V.; Hyman, D.; Calvo, E.; Griguolo, G.; Makker, V.; Doger, B.; Canziani, L.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Prospective identification of potentially actionable molecular alterations in cancers of unknown primary
    Meeting Abstract

    Varghese, A. M.; Hyman, D. M.; Zehir, A.; Vakiani, E.; Klimstra, D. S.; Ladanyi, M.; Berger, M. F.; Solit, D. B.; Saltz, L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases
    Meeting Abstract

    Schrader, K. A.; Cheng, D. T.; Vijai, J.; Prasad, M.; Walsh, M.; Zehir, A.; Thomas, T.; Benayed, R.; Stadler, Z. K.; Ashraf, A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I, first-in-human dose study of the dual PI3K/mTOR inhibitor LY3023414 (LY) in patients (pts) with advanced cancer
    Meeting Abstract

    Moore, K. N.; Varghese, A. M.; Hyman, D. M.; Callies, S.; Lin, J.; Wacheck, V.; Pant, S.; Bauer, T. M.; Bendell, J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save